Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

Lean manufacturing isn't just a trendy concept; it's a strategic framework designed to streamline processes, slash costs and boost productivity. By minimizing waste and focusing on value-added ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...

This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of traditional CAR T cell production. This innovative approach could ...

The production of red blood cells from stem cells has emerged as a transformative approach to address chronic blood shortages and meet the increasing demand for transfusion therapies. By harnessing ...